Geneva, 18 January 2012 - Dr Margaret Chan was nominated today by the World Health Organization's Executive Board for a second term as Director-General of the Organization. The Director-General is WHO's chief technical and administrative officer and oversees the policy for the Organization's international health work.
This nomination will be submitted for approval to the 65th World Health Assembly, scheduled to meet in Geneva from 21-26 May 2012.
If confirmed by the World Health Assembly, Dr Chan's new term will begin on 1 July 2012 and continue until 30 June 2017.
The Executive Board is composed of 34 individuals technically qualified in the field of health. Members are elected for three-year terms. The Director of the Pan American Health Organization (PAHO), Dr. Mirta Roses, is participating in the meeting with representatives of countries of the Americas who are serving on the Executive Board (Barbados, Canada, Chile, Ecuador, Mexico and the United States).
Only one candidate, Dr Chan, was proposed to the Executive Board (EB). WHO's Member States were given the opportunity to propose candidates between 4 July and 15 November 2011. Dr Chan presented her vision of the Organization's challenges and priorities to the Executive Board, which then agreed that her nomination be forwarded to the World Health Assembly.
Dr Margaret Chan, from the People's Republic of China, obtained her medical degree from the University of Western Ontario in Canada. She joined the Hong Kong Department of Health in 1978.
In 1994, Dr Chan was appointed Director of Health of Hong Kong. In her nine-year tenure as director, she launched new services to prevent the spread of disease and promote better health. She also introduced new initiatives to improve communicable disease surveillance and response, enhance training for public health professionals, and establish better local and international collaboration. She managed outbreaks of avian influenza and of severe acute respiratory syndrome (SARS).
In 2003, Dr Chan joined WHO as Director of the Department for Protection of the Human Environment. In June 2005, she was appointed Director, Communicable Diseases Surveillance and Response as well as Representative of the Director-General for Pandemic Influenza. In September 2005, she was named Assistant Director-General for Communicable Diseases.
Dr Chan was elected to the post of Director-General on 9 November 2006. Her current term runs through June 2012.
Gregory Härtl, WHO Media coordinator Mobile: +41 79 203 6715, Tel: +41 22 791 4458, Email:
HSS Recent Publications
- Regional bulletin for the availability of antimalalrial medicines: First Quarter 2014
- Core Competencies for Public Health: A Regional Framework for the Americas
- Report of the Expert Committee for the Selection and Inclusion of Medicines in the Pan American Health Organization Strategic Fund
- Regional bulletin for the availability of antimalarial medicines
- Caribbean Pharmaceutical Policy 
Click here to expand...
- CD42/15 Essential Public Health Functions
- CD42/13 Rev. Pharmaceutical Regulatory Harmonization in The Americas
- CSP26.R19 Extension of Social Protection in Health: Joint Initiative of the Pan American Health Organization and the International Labour Organization
- CD46 Regional Declaration on the New Orientations for Primary Health Care (Declaration of Montevideo)
- CD46.R5 Progress Report on the Global Safe Blood Initiative and Plan of Action for 2005-2010
- CSP27.R10 Regional Policy and Strategy for Ensuring Quality of Health Care, Including Patient Safety
- CSP27.R7 Regional Goals for Human Resources for Health 2007-2015
- CD48.R16 Health and International Relations: Linkages with National Health Development
- CD48.R15 Public Health, Innovation and Intellectual Property: a Regional Perspective
- CD48.R7 Improving Blood Availability and Transfusion Safety in the Americas
- CD49.R22 Integrated Health Services Delivery Networks Based on Primary Health Care
- CD49.R18 Policy Framework for Human Organ donation and transplantation
- CD49.R10 Policy on Research for Health
- CD50.R9 Strengthening National Regulatory Authorities for Medicines and Biologicals
- CD50.R7 Strategy for Health Personnel Competency Development in Primary Health Care-based Health Systems
- CD50/11 Strategy for Health Personnel Competency Development in Primary Health Care-based Health Systems
- CE148/INF/5 Implementation of the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property
- CSP28/INF/3 — Progress Reports on Technical Matters: Regional Goals for Human Resources for Health 2007-2015
- CSP28/INF/2 — Report of the PAHO/WHO Advisory Committee on Health Research
- CSP28/18, Rev. 1 Regional Consultation on the Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
- CSP28.R15 Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards
- CSP28/17, Rev. 1 Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards
- CSP28.R3 Expanded Textbook and Instructional Materials Program (PALTEX)
- CSP28/15 Expanded Textbook and Instructional Materials Program (PALTEX)
- CSP28.R9. Health Technology Assessment and Incorporation into Health Systems
- CSP28/11 Health Technology Assessment and Incorporation into Health Systems